BioSig Awarded CAGE Code by the Systems for Award Management (SAM)

Company moves forward with the qualification to bid for contacts, grants and to do business with the U.S. government Westport, CT, Aug. 03, 2020 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal […]

CryoLife Reports Second Quarter 2020 Financial Results

ATLANTA, July 30, 2020 /PRNewswire/ — Second Quarter and Recent Business Highlights: Achieved total revenues of $53.8 million in the second quarter 2020 versus $71.1 million in the second quarter of 2019– Total revenues decreased 24% and decreased 23% on a non-GAAP constant currency basis versus second quarter 2019 Completed $100.0 million convertible debt financing for general corporate […]

BioTelemetry, Inc. Announces Sales Agent Agreement with Boston Scientific Corporation

Company expands portfolio of solutions with groundbreaking insertable cardiac monitor system MALVERN, Pa., July 30, 2020 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today announced a sales agent […]

JanOne bolsters its scientific advisory board with two leaders in the medical field for vascular regeneration and interventional pain

Houston Methodist Research Institute Professor and Chair of the Department of Cardiovascular Sciences Dr. John Cooke and LSU Health Shreveport Vice Chancellor Dr. Alan Kaye Join the JanOne Team LAS VEGAS, July 30, 2020 /PRNewswire/ — JanOne Inc. (NASDAQ:JAN), a company focused on finding treatments for conditions that cause severe pain and bringing […]

Boston Scientific Announces Results For Second Quarter 2020

MARLBOROUGH, Mass., July 29, 2020 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated sales of $2.003 billion during the second quarter of 2020. This represents a decline of (23.9) percent on a reported basis, (23.1) percent on an operational1 basis and (28.7) percent on an organic2 basis, all compared to the prior year period. The company reported a […]